Mostrando 3 resultados de: 3
Filtros aplicados
Origen
scopus(3)
Use of rituximab for the treatment of rheumatoid arthritis: The Latin American context
ArticleAbstract:Palabras claves:Anti-CD20 antibody, Biologic therapy, Latin America, Rheumatoid Arthritis, rituximab, Treatment guidelinesAutores:Achurra-Castillo A.F., Alarcón G.S., Barile-Fabris L.A., Caballero-Uribe C.V., Cardiel M.H., Chávez-Corrales J.E., Claudio M. Galarza-Maldonado, Díaz-Coto J.F., Esteva-Spinetti M.H., Guibert-Toledano M., Keiserman M.W., Lomonte A.V., Massardo L., Mota L.M.H., Palazuelos I.F., Pineda-Villaseñor C., Pons-Estel B.A., Soriano E.R.Fuentes:scopusPrimary antiphospholipid syndrome in Latin American mestizo patients: Clinical and immunologic characteristics and comparison with European patients
ArticleAbstract: A great variety of clinical and immunological features have been described in patients with the antiPalabras claves:Anticardiolipin antibodies, antiphospholipid antibodies, Lupus anticoagulant, Primary antiphospholipid syndromeAutores:Cervera R., Claudio M. Galarza-Maldonado, Escárcega R.O., García-Carrasco M., López-Colombo A., Mejía-Romero R., Mendoza-Pinto C., Salinas-Saldivar S., Santos P., Soto-Vega E.Fuentes:scopusThe HELLP syndrome, antiphospholipid antibodies, and syndromes
OtherAbstract:Palabras claves:Autores:Asherson R., Claudio M. Galarza-Maldonado, Sanin-Blair J.Fuentes:scopus